JP2025500335A5 - - Google Patents

Info

Publication number
JP2025500335A5
JP2025500335A5 JP2024537335A JP2024537335A JP2025500335A5 JP 2025500335 A5 JP2025500335 A5 JP 2025500335A5 JP 2024537335 A JP2024537335 A JP 2024537335A JP 2024537335 A JP2024537335 A JP 2024537335A JP 2025500335 A5 JP2025500335 A5 JP 2025500335A5
Authority
JP
Japan
Prior art keywords
sequence number
sequence
seq
antisense oligonucleotide
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500335A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/086915 external-priority patent/WO2023118087A1/en
Publication of JP2025500335A publication Critical patent/JP2025500335A/ja
Publication of JP2025500335A5 publication Critical patent/JP2025500335A5/ja
Pending legal-status Critical Current

Links

JP2024537335A 2021-12-21 2022-12-20 Unc13aを標的とするアンチセンスオリゴヌクレオチド Pending JP2025500335A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21216561.7 2021-12-21
EP21216561 2021-12-21
PCT/EP2022/086915 WO2023118087A1 (en) 2021-12-21 2022-12-20 Antisense oligonucleotides targeting unc13a

Publications (2)

Publication Number Publication Date
JP2025500335A JP2025500335A (ja) 2025-01-09
JP2025500335A5 true JP2025500335A5 (cg-RX-API-DMAC7.html) 2026-01-06

Family

ID=79018929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537335A Pending JP2025500335A (ja) 2021-12-21 2022-12-20 Unc13aを標的とするアンチセンスオリゴヌクレオチド

Country Status (5)

Country Link
US (1) US20240327845A1 (cg-RX-API-DMAC7.html)
EP (1) EP4453207A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025500335A (cg-RX-API-DMAC7.html)
CN (1) CN118974254A (cg-RX-API-DMAC7.html)
WO (1) WO2023118087A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2603454A (en) 2020-12-09 2022-08-10 Ucl Business Ltd Novel therapeutics for the treatment of neurodegenerative disorders
WO2023004049A1 (en) 2021-07-21 2023-01-26 AcuraStem, Inc. Unc13a antisense oligonucleotides
EP4599062A1 (en) * 2022-10-05 2025-08-13 Trace Neuroscience, Inc. Unc13a antisense oligonucleotides and uses thereof
CN122055620A (zh) * 2023-09-29 2026-05-15 豪夫迈·罗氏有限公司 肽生物标志物
US12612630B2 (en) 2024-03-05 2026-04-28 Takeda Pharmaceutical Company Limited Compositions and methods for splicing modulation of UNC13A

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016528873A (ja) * 2012-05-16 2016-09-23 ラナ セラピューティクス インコーポレイテッド 遺伝子発現を調節するための組成物及び方法
EP4185696A1 (en) * 2020-07-23 2023-05-31 F. Hoffmann-La Roche AG Oligonucleotides targeting rna binding protein sites
GB2603454A (en) * 2020-12-09 2022-08-10 Ucl Business Ltd Novel therapeutics for the treatment of neurodegenerative disorders
WO2022216759A1 (en) * 2021-04-06 2022-10-13 Maze Therapeutics, Inc. Compositions and methods for treating tdp-43 proteinopathy
US20240301415A1 (en) * 2021-05-21 2024-09-12 Ionis Pharmaceuticals, Inc. Compounds for modulating unc13a expression
WO2023004049A1 (en) * 2021-07-21 2023-01-26 AcuraStem, Inc. Unc13a antisense oligonucleotides

Similar Documents

Publication Publication Date Title
US10369232B2 (en) Allele selective gene editing and uses thereof
JP2025501457A5 (cg-RX-API-DMAC7.html)
US9157081B2 (en) Chimeric oligomeric compounds for modulation of splicing
CN110079525A (zh) 反义核酸
US20240327845A1 (en) Antisense oligonucleotides targeting unc13a
JP2025501457A (ja) Actl6bを標的とするアンチセンスオリゴヌクレオチド
US20250051772A1 (en) Antisense Oligonucleotide for Targeting Progranulin
JP2025518522A5 (cg-RX-API-DMAC7.html)
WO2022018155A1 (en) Lna oligonucleotides for splice modulation of stmn2
US20260132403A2 (en) Antisense oligonucleotides for targeting progranulin
CA3135794A1 (en) Angptl2 antisense oligonucleotides and uses thereof
WO2020038971A1 (en) Antisense oligonucleotides targeting vcan
US20220403388A1 (en) Oligonucleotide Progranulin Agonists
US20230212572A1 (en) Guanosine Analogues for Use in Therapeutics Polynucleotides
HK40111667A (en) Antisense oligonucleotides targeting unc13a
HK40106800A (en) Antisense oligonucleotides targeting actl6b
HK40113673A (en) Antisense oligonucleotide
HK40111119A (en) Oligonucleotide gba agonists
HK40114073A (en) Antisense oligonucleotides targeting cfp-elk1 intergene region
WO2024126654A1 (en) Antisense oligonucleotides targeting actl6b
HK40117040A (en) Antisense oligonucleotides for targeting progranulin
RU2024137893A (ru) Улучшенные олигонуклеотиды, нацеленные на сайты рнк-связывающих белков